Family building options for heterosexual couples
When diagnosing infertility, the physicians at Western Fertility Institute consider the reproductive health of both the male and female partner. Testing both partners in an important step in diagnosing infertility as there are various causes of infertility both in men and women. The physicians at Western Fertility Institute recommend evaluating both the female and male partner prior to starting any infertility treatments to avoid losing valuable time with ineffective treatments that aren’t addressing the specific cause of infertility.
The physicians at Western Fertility Institute will evaluate the female partner by performing the following tests:
Testing to evaluate Ovarian Reserve
Anti-Mullerian Hormone blood test (AMH)
Follicle Stimulating Hormone (FSH)/Estradiol blood test
Antral Follicle Count
Testing to Determine Uterine Factor
MRI of the Uterus
Testing to Determine Tubal Factor
The physicians at Western Fertility Institute will evaluate the male partner by performing the following tests:
Sperm Chromatin Structure Assay (SCSA)
Once the physicians at Western Fertility Institute have determined the cause of infertility the next step is to establish the best treatment option for you and your partner. A few of the most common treatment options include the following:
What is Sex Selection?
It is common for many patients to be curious about the ability to choose the sex of their baby. This is known as Sex Selection (also commonly referred to as Gender Selection). Through genetic testing, this is possible for our patients undergoing IVF at Western Fertility Institute. A By-product of the genetic testing performed on the embryos called PGT-A allows for differentiation between male and female embryos since the sex of each embryo is identifiable by their chromosomes.
How does Sex Selection Work?
Sex selection through Preimplantation Genetic Testing for Aneuploidy (PGT_A) testing allows patients to select the sex of their embryos with almost 100% accuracy. Our highly skilled embryologists will biopsy a single cell from the embryo and send it to a third-party laboratory for PGT-A testing. The PGT-A results will show if each embryo has the proper number of chromosomes as well as the prospective of sex. Embryos containing two X chromosomes are female, while male embryos will contain one X and one Y chromosome. This allows the patient to choose a PGT-A embryo of a desired sex for transfer.
Why Do People Use Sex Selection?
Patients choose to use sex selection as an option for multiple reasons. In some cases, it can be used for medical reasons. Sex selection allows for the prevention of sex-linked genetic diseases and chromosomal disorders. For instance, there are certain disorders, linked to the X or Y chromosomes, that have the potential to be passed on to only a son or only a daughter. In other cases, sex selection can be used for what is known as "family balancing". Family balancing is when the patient chooses a specific sex in order to fulfill their desire of a balanced family. This can include choosing a sex based on a previously lost child, because they feel better equipped to raise a specific sex, or they want representation of both sexes in their family.